Dihydroergotamine mesylate
Dihydroergotamine Mesylate is a prescription injectable medication used to treat migraines and cluster headaches. It comes in a 1 mg/mL solution for intramuscular, intravenous, or subcutaneous administration. Manufactured by Gland Pharma Limited under ANDA215623. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dihydroergotamine Mesylate is a prescription injectable medication used to treat migraines and cluster headaches. It comes in a 1 mg/mL solution for intramuscular, intravenous, or subcutaneous administration. Manufactured by Gland Pharma Limited under ANDA215623. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dihydroergotamine mesylate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dihydroergotamine mesylate — ANDA 215623 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215623"
}
]
|
| identifier | ANDA215623 |
| issued | 2016-09-16 |
| keyword |
[
"fda",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dihydroergotamine mesylate |
